| Sarcoma Diagnosis and Treatment | Lifetime | 90 | JP 3 | 99.55 |
| Bone Tumor Diagnosis and Treatments | Lifetime | 83 | JP 6 | 99.23 |
| Cardiac tumors and thrombi | Lifetime | 89 | JP 5 | 99.06 |
| Oral and Maxillofacial Pathology | Lifetime | 164 | JP 3 | 98.92 |
| Cancer Mechanisms and Therapy | Lifetime | 96 | JP 4 | 98.83 |
| Soft tissue tumor case studies | Lifetime | 79 | JP 3 | 98.80 |
| Chromatin Remodeling and Cancer | Lifetime | 48 | JP 2 | 98.41 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | Lifetime | 313 | JP 68 | 98.61 |
| Tumors and Oncological Cases | Lifetime | 148 | JP 3 | 98.39 |
| Vascular Tumors and Angiosarcomas | Lifetime | 98 | JP 5 | 98.42 |
| Gastrointestinal Tumor Research and Treatment | Lifetime | 324 | JP 89 | 98.12 |
| Pancreatic and Hepatic Oncology Research | Lifetime | 850 | JP 111 | 98.20 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 919 | JP 36 | 98.11 |
| Cancer-related gene regulation | Lifetime | 635 | JP 64 | 97.10 |
| Neuroendocrine Tumor Research Advances | Lifetime | 718 | JP 60 | 97.71 |
| Neurofibromatosis and Schwannoma Cases | Lifetime | 268 | JP 9 | 97.20 |
| Cancer Diagnosis and Treatment | Lifetime | 886 | JP 53 | 96.04 |
| Metastasis and carcinoma case studies | Lifetime | 562 | JP 237 | 96.24 |
| Ear and Head Tumors | Lifetime | 391 | JP 14 | 96.22 |
| Medical Imaging and Pathology Studies | Lifetime | 990 | JP 118 | 95.73 |
| Musculoskeletal synovial abnormalities and treatments | Lifetime | 394 | JP 22 | 95.50 |
| Soft tissue tumors and treatment | Lifetime | 147 | JP 8 | 91.85 |
| IgG4-Related and Inflammatory Diseases | Lifetime | 645 | JP 230 | 84.72 |
| Mechanisms of cancer metastasis | Lifetime | 278 | JP 37 | 81.56 |
| FOXO transcription factor regulation | Lifetime | 809 | JP 56 | 76.35 |
| Beetle Biology and Toxicology Studies | Lifetime | 944 | JP 64 | 41.00 |
| Sarcoma Diagnosis and Treatment | 2021-2025 | 201 | JP 12 | 95.84 |
| Chromatin Remodeling and Cancer | 2021-2025 | 65 | JP 2 | 89.28 |
| Bone Tumor Diagnosis and Treatments | 2021-2025 | 163 | JP 17 | 91.40 |
| Cardiac tumors and thrombi | 2021-2025 | 171 | JP 8 | 88.85 |
| Vascular Tumors and Angiosarcomas | 2021-2025 | 109 | JP 5 | 88.40 |
| Cancer and Skin Lesions | 2021-2025 | 183 | JP 14 | 86.00 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | 2021-2025 | 787 | JP 119 | 89.58 |
| Soft tissue tumor case studies | 2021-2025 | 123 | JP 9 | 83.40 |
| Renal and related cancers | 2021-2025 | 901 | JP 58 | 81.46 |
| Ear and Head Tumors | 2021-2025 | 360 | JP 45 | 78.41 |
| Tumors and Oncological Cases | 2021-2025 | 348 | JP 19 | 76.50 |
| Molecular Biology Techniques and Applications | 2021-2025 | 975 | JP 30 | 67.73 |
| Neurofibromatosis and Schwannoma Cases | 2021-2025 | 886 | JP 57 | 69.90 |
| Phagocytosis and Immune Regulation | 2021-2025 | 915 | JP 23 | 65.91 |
| Hedgehog Signaling Pathway Studies | 2021-2025 | 518 | JP 30 | 60.62 |
| Congenital gastrointestinal and neural anomalies | 2021-2025 | 811 | JP 51 | 47.35 |
| Soft tissue tumors and treatment | 2021-2025 | 272 | JP 17 | 24.70 |